Patients with cystic fibrosis do not have an increased risk of adverse events after endoscopic retrograde cholangiopancreatography: a propensity-matched analysis
ERCP in CF patients demonstrated comparable adverse event rates to non-CF controls. These findings support the procedural safety of ERCP in this population, though further prospective studies are needed to validate these results and clarify risk by indication.
Authors
- Mahmoud Y. Madi (ORCID: https://orcid.org/0000-0001-5759-3386)
Institutions
- Ascension Via Christi (US)
Publication Details
- Journal
- Annals of Gastroenterology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.20524/aog.2025.0983
- Primary Topic
- Esophageal and GI Pathology
- Type
- article
- Field-Weighted Citation Impact
- 0.00